erythromycin lactobionate

Erythromycin lactobionate is a macrolide antibiotic that exerts its antibacterial activity by inhibiting bacterial protein synthesis. It achieves this by reversibly binding to the 50S ribosomal subunit of susceptible bacteria, thereby preventing the translocation of peptides. This action can be bacteriostatic or bactericidal, depending on the drug concentration and the susceptibility of the organism. It is primarily administered intravenously for the treatment of various bacterial infections, including respiratory tract infections, skin and soft tissue infections, and pelvic inflammatory disease.

Brand names

Erythrocin LactobionateErythrocin IVErythromycin Lactobionate for Injection

Other names

erythromycin lactobionate for injection, USP